Abstract
Excessive proliferation and migration of vascular smooth muscle cells have been implicated in the pathogenesis of atherosclerosis and restenosis after balloon angioplasty. These processes are mainly mediated by growth factors and cytokines released by various cells in the vessel wall. However, the role of free lipids in these events are not very clear. Vascular smooth muscle cell growth factors and cytokines can activate phospholipases with the release of arachidonic acid which can be further metabolized by several pathways including the lipoxygenase pathway. Lipoxygenase products have been shown to have potent inflammatory, growth and chemoattractant effects in cells. This chapter examines the role of the lipoxygenase pathway in the growth promoting effects of angiotensin II and the chemotactic effects of platelet-derived growth factor in vascular smooth muscle cells. In addition, this chapter also examines the effects of hyperglycemia on the regulation and function of the lipoxygenase pathway, in order to evaluate potential mechanisms for the accelerated cardiovascular disease observed in diabetics.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Liscovitch, M. (1992) Crosstalk among multiple signal-activated phospholipases. Trends Biochem. Sci. 17: 393–399.
Millar, J.B.A., Rozengurt, E. (1990) Arachidonic acid release by bombesin. A novel postreceptor target for heterologous mitogenic desensitization. J. Biol. Chem. 265: 19973–19979.
DiMarzo, V. (1995) Arachidonic acid and eicosanoids as targets and effectors in second messenger interactions. Prost. Leuk. Essent. Fatty Acids. 53: 239–254.
Smith, W.L. (1989) The eicosanoids and their biochemical mechanisms of action. Biochem. J 259: 315–324.
Yamamoto, S. (1991) “Enzymatic” lipid peroxidation: Reactions of mammalian lipoxygenases. Free Radical Biology and Medicine 10: 149–159.
Nadler, J., Natarajan, R., Stern, N. (1987) Specific action of the lipoxygenase pathway in mediating angiotensin II-induced aldosterone synthesis in isolated adrenal glomerulosa cells. J. Clin. Invest. 80: 1763–1769.
Natarajan, R., Stern, N., Hseuh, W., Do, Y., Nadler, J. (1988) Role of the lipoxygenase pathway in mediating angiotensin II-induced aldosterone biosynthesis in human adrenal glomerulosa cells. J. Clin. Endocrinol. Metab. 67: 584–591.
Antonipillai, I., Nadler, J., Robin, E.C., Horton, R. (1987) The inhibitory role of 12-and 15-lipoxygenase products on renin release. Hypertension 10: 61–66.
Antonipillai, L, Horton, R., Natarajan, R., Nadler, J. (1989) A 12-lipoxygenase product of arachidonate metabolism is involved in angiotensin action on renin release. Endocrinology 125: 2028–2034.
Natarajan, R., Gonzales, N., Hornsby, P.J., Nadler, J. (1992) Mechanism of angiotensin II-induced proliferation in bovine adrenal cortical cells. Endocrinology 131: 1174–1180.
Yamamoto, S. (1992) Mammalian lipoxygenases: molecular structures and functions. Biohim. Biophys. Acta. 1128: 117–131.
Funk, CD. (1996) The molecular biology of mammalian lipoxygenases and the quest for eicosanoid functions using lipoxygenase-deficient mice. Biochimica et Biophysica Acta 1304: 65–84.
Sigal, E. (1991) The molecular Biology of mammalian arachidonic acid metabolism. Am. J. Physiol 260 (Lung Cell. Mol. Physiol.): L13–L28.
Funk, CD., Furci, L., FitzGerald, G.A. (1990) Molecular cloning, primary structure and expression of the human platelet/erythroleukemia cell 12-lipoxygenase. Proc. Natl Acad. Sci. USA 87: 5638–5642.
Izumi, T., Hoshiko, S., Radmark, O., Samuelsson, S. (1990) Cloning of the cDNA for human 12-lipoxygenase. Proc. Natl. Acad. Sci. USA 87: 7477–7481.
Yoshimoto, T., Suzuki, H., Yamamoto, S., Takai, T., Yokoyama, C, Tanabe, T. (1990) Cloning and sequence analysis of the cDNA for arachidonate 12-lipoxygenase of porcine leukocytes. Proc. Natl. Acad. Sci. USA 87: 2142–2146.
Ueda, N., Hiroshima, A., Natsui, K., Shinjo, F., Yoshimoto, T., Yamamoto, S., Ii, K., Gerozissis, Dray, F. (1990) Localization of arachidonate 12-lipoxygenase in parenchymal cells of porcine anterior pituitary. J. Biol. Chem. 265: 2311–2316.
Natarajan, R., Gu, J.L., Rossi, J., Gonzales, N., Lanting, L., Xu, L., Nadler, J. (1993) Elevated glucose and angiotensin II increase 12-lipoxygenase activity and expression in porcine aortic smooth muscle cells. Proc. Natl. Acad. Sci. USA 90: 4947–4951.
Gu, J.L., Natarajan, R., Ben-Ezra, J., Valente, G., Scott, S., Yoshimoto, T., Yamamoto, S., Rossi, J.J., Nadler, J. (1994) Evidence that a leukocyte-type of 12-lipoxygenase is expressed and regulated by angiotensin II in human adrenal glomerulosa cells. Endocrinology 134: 70–77.
Kim, J.A., Gu, J.L., Natarajan, R., Esteban, J., Berliner, J.A., Nadler, J. (1995) A leukocyte-type of 12-lipoxygenase is expressed in human vascular and mononuclear cells: evidence for upregulation by angiotensin II. Arterioscler. Throm. Vase. Biol. 15: 942–948.
Sigal, E., Craik, C.S., Highland, E., Grunberger, D., Costelo, L.L., Dixon, R.A.F., Nadel, J.A. (1988). Molecular cloning and primary structure of human 15-lipoxygenase. Biochem. Biophys. Res. Commun. 157: 457–464.
DeMarzo, N., Sloane, D.L., Dicharry, L., Highland, E., Sigal, E. (1992) Molecular cloning and expression of an airway 12-lipoxygenase. Am. J. Physiol. 262: L 198–207.
Chen, X, Kurre, U, Jenkins, N.A., Copeland, N.G., Funk, CD. (1994) cDNA cloning, expression, mutagenesis c-terminal iso-leucine, genomic structure, and chromosomal localizations of murine 12-lipoxygenases. J. Biol. Chem. 269: 13979–13987.
Steinberg, D., Parthasarathy, S., Carew, T.E., Khoo, J.C, Witztum, J.L. (1989) Beyond Cholesterol. Modifications of low density lipoprotein that increase its atherogenecity. New Engl J. Med. 320: 915–924.
Parthasarathy, S., Wieland, E., Steinberg, D. (1989) A role for endothelial cell lipoxygenase in the oxidative modification of low density lipoprotein. Proc. Natl Acad. Sci. USA. 86: 1046–1050.
Yla-Hertualla, S., Rosenfeld, M.E., Parthasarathy, S., Glass, C.K., Sigal, E., Witztum, J.L., Steinberg, D. (1990) Colocalization of 15-LO mRNA and protein with epitopes of oxidized low density lipoprotein in macrophage-rich areas of atherosclerotic lesions. Proc. Natl. Acad. Sci. USA. 87: 6959–6963.
Simon, T.C., Makheja, A.N., Bailey, J.M. (1989) Formation of 15-hydroxyeicosa-tetraenoic acid (15-HETE) as the predominant eicosanoid from Watanabe heritable hyperlipidemic and cholesterol-fed rabbits. Atherosclerosis 75: 31–38.
Wang, T., Powell, W. (1991) Increased levels of monohydroxy metabolites of arachidonic and linoleic acids in LDL and aorta from atherosclerotic rabbits. Biochem. Biophys. Acta. 1084: 129–138.
Kuhn, H., Belkner, J., Zaiss, S., Fahrenklemper, T., and Wohlfeil, S. (1994) Involvement of 15-lipoxygenase in early stages of atherogenesis. J. Exp. Med. 179: 1903–1911.
Folcik, V.A., Nivar-Aristy, R.A., Krajewski, L.P., Cathcart, M.A. (1995) Lipoxygenase contributes to the oxidation of lipids in human atherosclerotic plaques. J. Clin. Invest. 96: 504–510.
Benz, D.J., Mol, M., Ezaki, M., Mori-Ito, N., Zelan, I., Miyanohara, A., Friedmann, T., Parthasarathy, S., Steinberg, D., Witztum, J.L. (1995) Enhanced levels of lipoperoxides in low density lipoprotein incubated with murine fibroblasts expressing high levels of human 15-lipoxygenase. J. Biol. Chem. 270: 5191–5197.
Scheidegger, K.J., Butler, S., Witztum, J. L. (1997) Angiotensin II increases macrophage-mediated modification of low density lipoprotein via the lipoxygenase pathway. J. Biol. Chem. 272: 21609–21615.
Gerrity, R., Nadler, J., Natarajan, R. (1997) Oxidant stress in a new swine model of diabetes-induced accelerated atherosclerosis. Circulation 96: 1–175, Abstract 967.
Sultana, C, Shen, Y., Rattan, V., Kalra, V.K. (1996) Lipoxygenase metabolites induced expression of adhesion molecules and transendothelial migration of monocyte-like HL-60 cells is linked to protein kinase C activation. J. Cell. Physiol. 167: 477–487.
Stern N, Golub M, Nozawa K, Berger M, Knoll E, Yanagawa N, Natarajan R, Tuck ML, Nadler J. (1989) Selective inhibition of angiotensin Il-mediated vasoconstriction by lipoxygenase blockade. Am. J. Physiol. 257: H434–H443.
Antonipillai I, Horton R, Natarajan R, Nadler J. (1989) A 12-lipoxygenase product of arachidonate metabolism is involved in angiotensin action on renin release. Endocrinology. 125: 2028–2034.
Nozawa K, Tuck ML, Golub M, Eggena P, Nadler JL, Stern N. (1990) Inhibition of lipoxygenase pathway reduces blood pressure in renovascular hypertensive rats. Am. J. Physiol 259: H1774–H1780.
Stern, N, Nozawa, K, Golub, M., Eggena, P, Knoll, E, Tuck, M.L. (1993) The lipoxygenase inhibitor phenidone is a potent hypotensive agent in the spontaneously hypertensive rat. Am. J. Hyperten. 6: 52–58.
Stern N, Eldad KS, Knoll E. (1996) Platelet lipoxygenase in spontaneously hypertensive rats. Hypertension. 27: 1149–1152
Sasaki, M., Hori, M.T., Hino, T., Golub, M.S., Tuck, M.L. (1997) Elevated 12-lipoxygenase in the spontaneously hypertensive rat. Am. J. Hyperten. 10: 371–378.
Natarajan, R., Gonzales, N., Xu, L., Nadler, J. (1992) Vascular smooth muscle cells exhibit increased growth in response to elevated glucose. Biochem. Biophys. Res. Commun. 187: 552–560.
Setty, B.N.Y., Stuart, M.J. (1986) 15-hydroxy-5, 8, l1, 13,-eicosatetraenoic acid inhibits human vascular cyclooxygenase. J. Clin. Invest. 77: 202–211.
Brown, M.L., Jakubowski, J., Leventis, L.L., Deykin, D. (1988) Elevated glucose alters eicosanoid release from porcine aortic endothelial cells. J. Clin. Invest. 82: 2136–2141.
Setty, B.N.Y., Graeber, J.E., Stuart, M.J. (1987) The mitogenic effects of 15-and 12-hydroxyeicosatetraenoic acids on endothelial cells may be mediated via diacylglycerol kinase inhibition. J. Biol. Chem. 262: 17613–17622.
Natarajan, R., Bai, W., Lanting, L., Gonzales, N., Nadler, J. (1997) Effects of high glucose on vascular endothelial growth factor expression in vascular smooth muscle cells. Am. J. Physiol. 273 (Heart Circ. Physiol 42): H2224–H2231.
Nakao, J., Ooyama, T., Ito, H., Chang, W.C., Murota, S. (1982) Comparative effects of lipoxygenase products of arachidonic acid on rat aortic smooth muscle cell migration. Atherosclerosis 44: 339–342.
Antonipillai, I., Nadler, J., Jost-Vu, E., Bughi, S., Natarajan, R., Horton, R. (1996) A 12-lipoxygenase product, 12-hydroxyeicosatetraenoic acid is increased in diabetes with incipient and early renal disease. J. Clin. Endocrinol. Metabol. 81: 1940–1945
Conrad, D.J., Kuhn, H., Mulkins, M., Highland, E., Sigal, E. (1992) Specific inflammatory cytokines regulate the expression of human monocyte 15-lipoxygenase. Proc. Natl. Acad. Sci. USA 89: 217–222.
Nasser, G.M., Morrow, J.D., Robert II, L.J., Lakkis, F.J., Badr, K.F. (1994) Induction of 15-lipoxygenase by IL-13 in human blood monocytes. J. Biol. Chem. 269: 27631–27634.
Natarajan, R., Bai, W., Gu, J.L., Rangarajan, V., Nadler, J. (1996) Platelet-derived growth factor BB mediated regulation of 12-lipoxygenase in porcine aortic smooth muscle cells. J. Cell. Physiol. 169: 391–400.
Dethlefsen, S.M, Sheprod, D., D’Amore, P.A. (1994) Arachidonic acid metabolites in bFGF-, PDGF-and serum-stimulated vascular cell growth. Exp. Cell. Res. 212: 262–273.
Nakao, J., Ito, H., Chang, W.C., Koshihara, Y., Murota, S. (1983) Aortic smooth muscle cell migration caused by PDGF is mediated by lipoxygenase products of arachidonic acid. Biochem. Biophys. Res. Commun. 112: 866–871.
Natarajan, R., Rosdahl, J., Gonzales, N., Bai, W. (1995) The regulation of vascular smooth muscle cell 12-lipoxygenase by inflammatory cytokines. J. Invest. Med. 43: 309A.
Natarajan, R., Gonzales, N., Lanting, L., Nadler, J. (1994) Role of the lipoxygenase pathway in angiotensin II-induced vascular smooth muscle cell hypertrophy. Hypertension 23[suppl I]:I-142-I-147.
Wen, Y., Nadler, J., Gonzales, N., Scott, S., Clauser, E., Natarajan, R. (1996) Mechanisms of angiotensin II type 1 receptor induced mitogenic responses: Key role of 12-lipoxygenase and biphasic mitogen activated protein kinase activity. Am. J. Physiol. 271: (Cell. Physiol) 40: C1212–C1220.
Haliday, E., Ramesha, C, Ringold, G. (1991) TNF induces c-fos via a novel pathway requiring the conversion of arachidonic acid to a lipoxygenase metabolite. Embo J. 10: 109–115.
Yu, C.L., Tsai, M., Stacey, D.W. (1990) Serum stimulation of NIH 3T3 cells induces the production of lipids able to inhibit GTPase-activating protein activity. Molr. Cell. Biol. 10: 6683–6689.
Shearman, M.S., Naor, Z., Segikuchi, K., Kishimoto, A., Nishizuka, Y. (1989) Selective activation of the y-subspecies of protein kinase C from bovine cerebellum by arachidonic acid and its lipoxygenase metabolites. FEBS Lett. 243: 177–182.
Natarajan, R., Lanting, L., Xu, L., Nadler, J.L. (1994) Role of specific isoforms of protein kinase C in angiotensin II and lipoxygenase action in rat adrenal glomerulosa cells. Mol Cell Endocrinol 101: 59–66.
Legrand, A.B., Lawson, J.A., Meyrick, B.O., Blair, LA., Oates, J.A. (1991) Substitution of 15-hydroxyeicosatetraenoic acid in the phosphoinositide signaling pathway. J. Biol Chem. 266: 7570–7577.
Takahashi, Y., Glasgow, W.C., Suzuki, H., Taketani, Y., Yamamoto, S., Anton, M., Kuhn, H., Brash, A. (1993). Investigation of the oxygenation of phopspholipids by the porcine leukocyte and human platelet arachidonate 12-lipoxygenases. Eur. J. Biochem. 218: 165–171.
Saito, F., Hori, M.T., Ideguchi, Y., Berger, M., Golub, M., Stern, N., Tuck, M.L. (1992) 12-lipoxygenase products modulate calcium signals in vascular smooth muscle cells. Hypertension 20: 138–143.
Liu, B., Khan, W.A., Hannun, Y.A., Timar, J., Taylor, J.D., Lundy, S., Butovich, I., Honn, K.V. (1995) 12(S)-Hydroxyeicosatetraenoic acid and 13(S)-hydroxyoctadecadienoic acid regulation of protein kinase C-α in melanoma cells: Role of receptor-mediated hydrolysis of inositol phospholipids. Proc. Natl Acad. Sci. USA 92: 9323–9327.
Rao, G., Baas, A.S., Glasgow, W.C., Eling, T.E, Runge, M.S., Alexander, R.W. (1994) Activation of MAP kinases by arachidonic acid and its metabolites in vascular smooth muscle cells. J. Biol. Chem. 269: 32586–32591.
Rao, G.N., Alexander, R.W., Runge, M.S. (1995) Linoleic acid and its metabolites, hydroperoxyocatadecadienoic acids, stimulate c-fos, c-jun, and c-myc mRNA expression, mitogen-activated protein kinase activation, and growth in rat aortic smooth muscle cells. J. Clin. Invest. 96: 842–847.
Wen, Y., Scort, S., Liu, Y., Gonzales, N., Nadler, J.L. (1997) Evidence that angiotensin II and lipoxygenase products activate the c-Jun NH2-terminal kinase. Circ. Res. 81: 651–655.
Davis, R.J. (1993) The mitogen-activated protein kinase signal transduction pathway. J. Biol. Chem. 268: 14553–14556.
Eling, T.E., Glasgow, W.C. (1994) Cellular proliferation and lipid metabolism: importance of lipoxygenases in modulating epidermal growth factor-dependent mitogenesis. Cancer Metastasis Rev. 13: 397–410
Gu, J.L., Veerapanane, D., Rossi, J., Natarajan, R., Thomas, L., Nadler, J. (1995) Ribozyme-mediated inhibition of expression of leukocyte-type 12-lipoxygenase in porcine aortic vascular smooth muscle cells. Circ. Res. 77: 14–20.
Gu, J.L., Nadler, J., Rossi, J.J. (1997) Use of a hammerhead ribozyme with cationic liposomes to reduce leukocyte-type 12-lipoxygenase expression in vascular smooth muscle. Mol Cell Biochem. 172: 47–57.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer Science+Business Media New York
About this chapter
Cite this chapter
Natarajan, R., Nadler, J. (1998). Angiotensin II, Growth Factors and the Lipoxygenase Pathway. In: Levin, E.R., Nadler, J.L. (eds) Endocrinology of Cardiovascular Function. Endocrine Updates, vol 1. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-5569-8_4
Download citation
DOI: https://doi.org/10.1007/978-1-4615-5569-8_4
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-7547-0
Online ISBN: 978-1-4615-5569-8
eBook Packages: Springer Book Archive